Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,316,605,688
-$141,885,890 QoQ
Shares Held
10,421,131
-0.4% QoQ
Ownership
0.840%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#21
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $26,335,991,083 across 11 Drug Manufacturers - General names. GILD ranks #7 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,145,229 | $6,171,342,532 | |
| 2 | JNJ |
Johnson & Johnson
|
19,286,904 | $4,898,295,007 | |
| 3 | AZN |
Astrazeneca PLC
|
25,750,245 | $4,882,761,455 | |
| 4 | ABBV |
AbbVie Inc.
|
11,548,053 | $2,905,952,055 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,873,343 | $2,425,224,575 | |
| 6 | AMGN |
Amgen Inc
|
3,816,942 | $1,382,191,036 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
10,421,131 | $1,316,605,688 | |
| 8 | PFE |
Pfizer Inc
|
43,233,122 | $1,041,053,576 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,316,605,688 | 10,421,131 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,458,491,578 | 10,464,889 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,266,383,819 | 10,317,613 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,133,376,489 | 10,210,599 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,086,098,595 | 9,796,145 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,152,245,444 | 10,283,315 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $915,500,406 | 9,911,231 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $836,933,134 | 9,982,504 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $683,180,712 | 9,957,451 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $748,988,060 | 10,225,093 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $839,745,445 | 10,365,948 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $781,758,267 | 10,431,789 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $833,826,571 | 10,819,081 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $876,917,977 | 10,569,097 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $917,463,754 | 10,686,823 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $683,556,537 | 11,080,508 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $701,313,999 | 11,346,287 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $690,140,840 | 11,608,761 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $782,492,700 | 10,776,652 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $754,492,247 | 10,801,607 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $709,094,801 | 10,297,630 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $601,924,007 | 9,313,384 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $545,578,565 | 9,364,548 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $575,314,048 | 9,104,511 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $703,924,059 | 9,149,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $635,187,722 | 8,496,358 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||